LSM4
U6 snRNA-associated Sm-like protein LSm4
Also known as: LSM4_HUMAN, YER112W
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y4Z0
- Gene
- LSM4
- Ensembl
- ENSG00000130520
- Chromosome
- 19
- Canonical length
- 139 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes a member of the LSm family of RNA-binding proteins. LSm proteins form stable heteromers that bind specifically to the 3'-terminal oligo(U) tract of U6 snRNA and may play a role in pre-mRNA splicing by mediating U4/U6 snRNP formation. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
Canonical amino-acid sequenceUniProt
139 residues, UniProt reviewed canonical sequence.
>Q9Y4Z0|LSM4
1 MLPLSLLKTA QNHPMLVELK NGETYNGHLV SCDNWMNINL REVICTSRDG DKFWRMPECY
61 IRGSTIKYLR IPDEIIDMVK EEVVAKGRGR GGLQQQKQQK GRGMGGAGRG VFGGRGRGGI
121 PGTGRGQPEK KPGRQAGKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LSM4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 138 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 138 nTPM
- cerebral cortex: 127 nTPM
- choroid plexus: 126 nTPM
- adrenal gland: 125 nTPM
- testis: 122 nTPM
- kidney: 122 nTPM
Single-cell type
- late spermatids: 1,065 nCPM
- extravillous trophoblasts: 556 nCPM
- migrating cytotrophoblasts: 455 nCPM
- differentiating spermatogonia: 425 nCPM
- esophageal basal cells: 390 nCPM
- hofbauer cells: 365 nCPM
Immune cell
- plasmacytoid DC: 360 nTPM
- total PBMC: 284 nTPM
- intermediate monocyte: 259 nTPM
- myeloid DC: 253 nTPM
- classical monocyte: 224 nTPM
- NK-cell: 221 nTPM
Brain region
- choroid plexus: 91 nTPM
- thalamus: 78 nTPM
- pons: 78 nTPM
- hypothalamus: 77 nTPM
- midbrain: 73 nTPM
- cerebral cortex: 71 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 1.6
- DepMap mean gene effect
- -1.79
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA splicing, via spliceosome
- nuclear-transcribed mRNA catabolic process
- P-body assembly
- RNA splicing
- spliceosomal snRNP assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LSM4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LSM4 as an antibody target. Whether an autoantibody or antibody against LSM4 could matter depends on whether native LSM4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LSM4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LSM4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...